Condition: Preterm Premature Rupture of Membrane · Pregnancy, High Risk · Preterm Birth · Sponsor: Ohio State University
To conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day course of ampicillin/amoxicillin and azithromycin or erythromycin to prolong pregnancy and decrease adverse perinatal outcomes among hospitalized pregnant individuals undergoing expectant management of PPROM \<34 weeks.
This description comes directly from the study's public registry record.
Marissa Berry, MD · 614-293-4780 · Marissa.Berry@osumc.edu
Always discuss trial participation with your own doctor first.
| The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine | Columbus, Ohio, United States | Recruiting |
| University of Texas Medical Branch | Galveston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06396078